文献速递消化系统肿瘤

姜黄素诱导不同分化程度人胃癌细胞凋亡及保护性自噬

[Curcumin induces apoptosis and protective autophagy in human gastric cancer cells with different degree of differentiation].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2017-01-01

研究姜黄素对不同分化程度人胃癌细胞株BGC-823和MKN-28凋亡与自噬的影响。姜黄素以时间及剂量依赖方式抑制两株细胞活力,48 h时IC50分别为15.18与15.84 μmol/L,差异无统计学意义(P=0.513);姜黄素剂量依赖地诱导凋亡并伴保护性自噬,自噬抑制剂3-甲基腺嘌呤可促进姜黄素诱导的凋亡。

要点

  • 姜黄素以时间及剂量依赖方式抑制BGC-823和MKN-28细胞活力。
  • 48 h时BGC-823与MKN-28的IC50分别为15.18与15.84 μmol/L,差异无统计学意义(P=0.513)。
  • 姜黄素剂量依赖地诱导凋亡,并诱导保护性自噬及抑制PI3K/Akt/mTOR通路活化。

核心结论

  • 姜黄素可在体外诱导不同分化程度胃癌细胞凋亡性死亡和保护性自噬,自噬抑制剂联合姜黄素可明显增强姜黄素的抗癌效果。

研究设计与样本

  • 体外研究:以不同浓度姜黄素处理不同分化程度人胃癌细胞株BGC-823和MKN-28,采用MTT法检测增殖、流式细胞术分析凋亡、吖啶橙染色观察自噬、Western blot检测凋亡与自噬相关蛋白。

主要发现

  • 姜黄素以时间及剂量依赖方式抑制BGC-823和MKN-28细胞活力。
  • 处理48 h后BGC-823的IC50为15.18 μmol/L,MKN-28为15.84 μmol/L,差异无统计学意义(P=0.513)。
  • 流式细胞术显示姜黄素以剂量依赖方式促进胃癌细胞凋亡。
  • Western blot显示BGC-823和MKN-28细胞中bax、active-caspase-3和active-caspase-9表达显著升高,bcl-2表达显著降低。
  • 姜黄素处理48 h后诱导细胞质酸性囊状小体形成、LC3-Ⅰ向LC3-Ⅱ转换及Beclin1、Atg7、Atg5-Atg12表达升高,并显著抑制PI3K/Akt/mTOR信号通路活化。

关键数值与推荐

  • 加入自噬抑制剂3-甲基腺嘌呤(3-MA)阻断自噬可显著促进姜黄素诱导的凋亡性细胞死亡。

临床怎么用

  • 作者认为自噬抑制剂联合姜黄素可能为其临床应用提供更有效的策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effect of curcumin on the apoptosis and autophagy of human gastric cancer cells with different degree of differentiation. Methods: Gastric cancer cell lines BGC-823 and MKN-28 were treated with curcumin at different concentrations. The effect of curcumin on cell proliferation was measured by MTT assay. Apoptosis was assessed by flow cytometry. Autophagy status was analyzed by acridine orange staining. The expression levels of apoptotic and autophagy-related proteins were detected by Western blot. Results: The cell viability of BGC-823 and MKN-28 was inhibited by curcumin in a time- and dose-dependent manner. At 48 h after treatment, the IC(50) value of BGC-823 (15.18 μmol/L) was close to that of MKN-28 (15.84 μmol/L), and the difference was not statistically significant (P=0.513). Meanwhile, flow cytometry showed that curcumin induced the apoptosis of gastric cancer cells in a dose-dependent manner. Western blot results showed that the expression of pro-apoptotic proteins bax, active-caspase-3 and active-caspase-9 was significantly increased in BGC-823 and MKN-28 cells, whereas that of the anti-apoptotic protein bcl-2 was strikingly reduced. In addition, the formation of acidic vesicular organelles in cytoplasm, conversion of LC3-Ⅰ to LC3-Ⅱ and increased levels of autophagy-related proteins Beclin1, Atg7 and Atg5-Atg12 were observed in curcumin-treated cells. Moreover, activation of PI3K/Akt/mTOR signaling pathway was also significantly suppressed after curcumin treatment. Blocking autophagy by adding the autophagy inhibitor 3-methyladenine (3-MA) significantly promoted the apoptotic cell death induced by curcumin. Conclusions: Curcumin induces apoptosis and protective autophagy in human gastric cancer cells in vitro. Curcumin combined with autophagy inhibitor may provide a more effective strategy for its clinical application. 目的: 探讨姜黄素诱导不同分化程度胃癌细胞的凋亡及保护性自噬作用。 方法: 采用一定梯度浓度的姜黄素处理不同分化程度的胃癌细胞株BGC-823和MKN-28,采用四甲基偶氮唑蓝法检测细胞的增殖情况,采用流式细胞术分析细胞的凋亡情况,采用吖啶橙染色观察细胞自噬的发生,采用Western blot检测细胞中凋亡通路相关蛋白和自噬标记蛋白的表达。 结果: 姜黄素以剂量和时间依赖的方式抑制BGC-823和MKN-28细胞的活力。姜黄素作用48 h后,BGC-823和MKN-28细胞的药物半数抑制浓度(IC(50))趋于接近,分别为15.18和15.84 μmol/L,差异无统计学意义(P=0.513)。流式细胞术检测结果显示,体外处理48 h后,姜黄素以剂量依赖的方式促进胃癌细胞的凋亡。Western blot检测结果显示,姜黄素可促进BGC-823和MKN-28细胞中bax、active-caspase-3和active-caspase-9凋亡相关蛋白的表达,下调bcl-2的表达。姜黄素处理BGC-823和MKN-28细胞48 h后,可诱导胃癌细胞质中酸性囊状小体的形成、LC3亚型转换以及Beclin1、Atg7和Atg5-Atg12等自噬相关蛋白表达水平的升高。姜黄素可显著抑制胃癌细胞中PI3K/Akt/mTOR信号通路的活化。在姜黄素处理胃癌细胞的体外培养体系中,加入自噬抑制剂3-甲基腺嘌呤,可促进胃癌细胞的凋亡。 结论: 姜黄素可在体外诱导不同分化程度的胃癌细胞凋亡性死亡和保护性自噬的发生,自噬抑制剂联合姜黄素可明显增强姜黄素的抗癌效果。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li W, Zhou Y, Yang J, et al. [Curcumin induces apoptosis and protective autophagy in human gastric cancer cells with different degree of differentiation]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28728293. doi:10.3760/cma.j.issn.0253-3766.2017.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。